Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $6.7 million.

  • GeoVax Labs' Liabilities and Shareholders Equity fell 3942.38% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 1157.11%. This contributed to the annual value of $8.2 million for FY2024, which is 1214.4% down from last year.
  • Latest data reveals that GeoVax Labs reported Liabilities and Shareholders Equity of $6.7 million as of Q3 2025, which was down 3942.38% from $5.4 million recorded in Q2 2025.
  • GeoVax Labs' Liabilities and Shareholders Equity's 5-year high stood at $38.6 million during Q3 2022, with a 5-year trough of $3.4 million in Q1 2024.
  • Over the past 5 years, GeoVax Labs' median Liabilities and Shareholders Equity value was $16.2 million (recorded in 2023), while the average stood at $16.6 million.
  • As far as peak fluctuations go, GeoVax Labs' Liabilities and Shareholders Equity soared by 244147.9% in 2021, and later plummeted by 8774.57% in 2024.
  • Over the past 5 years, GeoVax Labs' Liabilities and Shareholders Equity (Quarter) stood at $11.8 million in 2021, then skyrocketed by 165.73% to $31.3 million in 2022, then tumbled by 70.39% to $9.3 million in 2023, then dropped by 12.14% to $8.2 million in 2024, then decreased by 17.47% to $6.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $6.7 million for Q3 2025, versus $5.4 million for Q2 2025 and $10.8 million for Q1 2025.